Chroma ATE Inc. Launches GenXplore q4800 to the Global Market with CE-IVDR and FDA Approval

Chroma ATE Inc., a leading innovator in molecular diagnostics and laboratory automation, proudly announces the official launch of its flagship all-in-one qPCR system, GenXplore q4800, following recent CE-IVDR certification and FDA approval. With regulatory clearance in both the European Union and the United States, the GenXplore q4800 is now available for global distribution.

Designed as an open-platform, high-throughput system, the GenXplore q4800 delivers precision, flexibility, and ease of use, setting a new standard in real-time PCR performance. Its open design allows laboratories to expand their test menus, adapting to evolving diagnostic and research needs.

With CE-IVDR and FDA approvals secured, the GenXplore q4800 is ready to support clinical laboratories, diagnostic assay developers, and research institutions worldwide. The system accommodates various reagent formats and supports customizable workflows, making it ideal for a wide range of applications, including molecular diagnostics, infectious disease testing, oncology, and more.

Chroma ATE Inc. is now actively seeking global distributors and reagent partners to collaborate in delivering comprehensive, high-quality molecular testing solutions to the global healthcare community.

For more information about the GenXplore q4800, please visit https://www.chromaate.com/en/lifescience/genxploreq4800 or contact us info@chromaate.com